newsfilter
← Latest News
ACCESS Newswire·

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Measure taken to Comply with Nasdaq Rule 5550 Regarding Minimum Bid Price NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Protagenic Therapeutics, Inc. ("Protagenic Therapeutics" or the